Circular RNAs as a Diagnostic and Therapeutic Target in Cardiovascular Diseases

被引:14
|
作者
Joaquim, Victor Hugo Antonio [1 ]
Pereira, Noemy Pinto [1 ]
Fernandes, Tiago [1 ]
Oliveira, Edilamar Menezes [1 ]
机构
[1] Univ Sao Paulo, Sch Phys Educ & Sport, Lab Biochem & Mol Biol Appl Exercise, BR-05508030 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
circRNAs; cardiovascular diseases; physical exercise; ISCHEMIA-REPERFUSION INJURY; ABDOMINAL AORTIC-ANEURYSM; MYOCARDIAL-INFARCTION; CIRCRNA; EXPRESSION; DIFFERENTIATION; CIRCACTA2; LANDSCAPE; APOPTOSIS; BIOMARKER;
D O I
10.3390/ijms24032125
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Circular RNAs (circRNAs) are a family of noncoding RNAs (ncRNAs) that are endogenous and widely distributed in different species, performing several functions, mainly their association with microRNAs (miRNAs) and RNA-binding proteins. CVDs remain the leading cause of death worldwide; therefore, the development of new therapies and strategies, such as gene therapies or nonpharmacological therapies, with low cost, such as physical exercise, to alleviate these diseases is of extreme importance for society. With increasing evidence of ncRNA participating in the progression of CVDs, several studies have reported these RNAs as promising targets for diagnosis and treatment. There are several studies of CVDs and the role of miRNAs and lncRNAs; however, little is known about the new class of RNAs, called circRNAs, and CVDs. In this mini review, we focus on the mechanisms of circRNAs and CVDs.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Angiogenic circular RNAs: A new landscape in cardiovascular diseases
    Zhang, Tian-Rong
    Huang, Wei-Qiang
    MICROVASCULAR RESEARCH, 2020, 129
  • [22] Circular RNAs in liver diseases: Mechanisms and therapeutic targets
    Fu, Li-Yun
    Wang, Shu-Wei
    Hu, Meng-Yuan
    Jiang, Zhen-Luo
    Shen, Li-Li
    Zhou, Yu-Ping
    Guo, Jun-Ming
    Hu, Yao-Ren
    LIFE SCIENCES, 2021, 264
  • [23] MicroRNAs as a therapeutic target for cardiovascular diseases
    Mishra, Paras Kumar
    Tyagi, Neetu
    Kumar, Munish
    Tyagi, Suresh C.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (04) : 778 - 789
  • [24] Diagnostic and Therapeutic Nanoparticles in Cardiovascular Diseases
    Tyler, Patrick D.
    Kang, Peter M.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (42) : 6070 - 6080
  • [25] Circular RNAs in neuroblastoma: Pathogenesis, potential biomarker, and therapeutic target
    Fath, Mohsen Karami
    Benam, Sasan Pourbagher
    Salmani, Kiana
    Naderi, Sina
    Fahham, Zahra
    Ghiabi, Shamim
    Kia, Seyed Armin Houshmand
    Naderi, Malihe
    Darvish, Maryam
    Barati, Ghasem
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 238
  • [26] Translocator Protein (18 kDa): A Promising Therapeutic Target and Diagnostic Tool for Cardiovascular Diseases
    Qi, Xiaolong
    Xu, Jiahong
    Wang, Fei
    Xiao, Junjie
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2012, 2012
  • [27] Circular RNAs: novel diagnostic and therapeutic targets for ischemic stroke
    Wang, Qianwen
    Liu, Xu
    Zhao, Jingjing
    Zhu, Ruixia
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (10) : 1039 - 1049
  • [28] Exosomal circular RNAs: Biogenesis, effect, and application in cardiovascular diseases
    Hu, Xiaoyi
    Qin, Hongran
    Yan, Yi
    Wu, Wenhui
    Gong, Sugang
    Wang, Lan
    Jiang, Rong
    Zhao, Qinhua
    Sun, Yuanyuan
    Wang, Qian
    Wang, Shang
    Zhao, Hui
    Liu, Jinming
    Yuan, Ping
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [29] Circular RNAs: Potential biomarkers and therapeutic targets for autoimmune diseases
    Zhao, Ren-Jie
    Zhang, Wan-Ying
    Fan, Xing-Xing
    HELIYON, 2024, 10 (01)
  • [30] Circular RNAs as Potential Biomarkers and Therapeutic Targets for Metabolic Diseases
    Zaiou, Mohamed
    REVIEWS ON BIOMARKER STUDIES OF METABOLIC AND METABOLISM-RELATED DISORDERS, 2019, 1134 : 177 - 191